In this study, after MSC infusion, insulin sensitivity and glucose metabolism in T2D mice were significantly improved within 1 week, and the hypoglycemic effect gradually disappeared, consistent with previous studies [13, 21]. The gene discussed is INS; the disease is type 2 diabetes mellitus.